A comprehensive study reveals how the ‘Alzheimer's gene’ (APOE ε4) affects the nature of the disease. It is not simply that those with the gene variant tend to be more impaired (in terms of both memory loss and brain damage) than those without. Different parts of the brain (and thus different functions) tend to be differentially affected, depending on whether the individual is a carrier of the gene or not. Carriers displayed significantly greater impairment on tests of memory retention, while noncarriers were more impaired on tests of working memory, executive control, and lexical access. Consistent with this, carriers showed greater atrophy in the mediotemporal lobe, and noncarriers greater atrophy in the frontoparietal area. The findings have implications both for diagnosis and treatment.
Alzheimer's expressed differently in carriers and noncarriers of the Alzheimer’s gene
Reference
Wolk, D. A., & Dickerson, B. C. (2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease. Proceedings of the National Academy of Sciences, 107(22), 10256-10261. Retrieved from http://www.pnas.org/content/107/22/10256.abstract
Related News
Improving fitness may counteract brain atrophy in older adults, including those with MCI
A study involving 30 previously physically inactive older adults (aged 61-88) found that a three-month exercise program reversed some brain atrophy.
Participants included 14 with MCI. The exercise program included moderate intensity walking on a treadmill four times a week over a twelve-week period. On average, cardiorespiratory fitness improved by about 8% as a result of the training in both the healthy and MCI participants. Fitness was assessed using peak oxygen capacity rates.
Gene variation associated with brain atrophy in MCI
Submitted by Fiona McPherson
on
Analysis of data from 237 patients with mild cognitive impairment (mean age 79.9) has found that, compared to those carrying the ‘normal’ ApoE3 gene (the most common variant of the ApoE gene), the ApoE4 carriers showed markedly greater rates of shrinkage in 13 of 15 brain regions thought to be key components of the brain networks disrupted in Alzheimer’s.
http://www.eurekalert.org/pub_releases/2014-01/rson-gva010714.php
Coping with cognitive decline in MS
Cognitive impairment affects 40-65% of people with MS. Why? In the past year, a number of studies have helped us build a better picture of the precise nature of cognitive problems that may affect multiple sclerosis sufferers:
Omega 3 levels affect whether B vitamins can slow brain's decline
A study involving 266 people with mild cognitive impairment (aged 70+) has found that B vitamins are more effective in slowing cognitive decline when people have higher omega 3 levels.
Participants were randomly selected to receive either a B-vitamin supplement (folic acid, vitamins B6 and B12) or a placebo pill for two years. The vitamins had little to no effect for those with low levels of omega-3 fatty acids, but were very effective for those with high baseline omega-3 levels.
Genes linked to Alzheimer's
Five new risk genes for Alzheimer's disease
Genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer's disease, and confirmed 20 known others. The new genes are: IQCK, ACE, ADAM10, ADAMTS1 and WWOX.
The findings support developing evidence that groups of genes associated with specific biological processes, such as cell trafficking, lipid transport, inflammation and the immune response, are "genetic hubs" that are an important part of the disease process.
Vascular health linked to dementia risk
Optimal levels of cardiovascular health in older age associated with lower dementia risk
A French study involving 6,626 older adults (65+) found that having optimal levels in more measures of cardiovascular health (nonsmoking, weight, diet, physical activity, cholesterol, blood glucose and blood pressure) was associated with lower dementia risk and slower rates of cognitive decline. Dementia risk and rates of cognitive decline lowered with each additional metric at the recommended optimal level.
Benefits of exercise for the brain
Moderate intensity exercise can benefit memory performance
Three experiments involving a total of 59 people provides more evidence that moderate intensity exercise (e.g., brisk walking, water aerobics, cycling) is enough for cognitive improvement. Indeed, moderate intensity exercise had the most beneficial effect on memory performance.
Diabetes duration and severity associated with brain atrophy
Submitted by Fiona McPherson
on
A study involving 614 patients with type 2 diabetes (mean age 62) has found that longer duration of diabetes was associated with more brain volume loss, particularly in the gray matter. Roughly, for every 10 years of diabetes, the brain was similar to that of a non-diabetic person who was two years older.
However, the study did not confirm any association of diabetes characteristics with small vessel ischemic disease.
http://www.eurekalert.org/pub_releases/2014-04/rson-dda042214.php
Genes implicated in late-onset Alzheimer's disease
Submitted by Fiona McPherson
on
11 new genetic susceptibility factors for Alzheimer’s identified
The largest international study ever conducted on Alzheimer's disease (I-GAP) has identified 11 new genetic regions that increase the risk of late-onset Alzheimer’s, plus 13 other genes yet to be validated. Genetic data came from 74,076 patients and controls from 15 countries.
Eleven genes for Alzheimer's disease have previously been identified.
Mental imagery training improves multiple sclerosis patients' cognition
Training in a mental imagery technique has been found to help multiple sclerosis patients in two memory domains often affected by the disease: autobiographical memory and episodic future thinking.